SS Innovations Achieves First International Sale of Flagship Surgical Robotic System

SS Innovations International, Inc. (OTC: SSII) has filled its first international order. The company’s SSi Mantra surgical robotic unit has been delivered and installed in Aster Hospital, one of the premier hospitals in Dubai, United Arab Emirates.

Aster Hospital is part operated by Aster DM Healthcare Limited, a publicly-traded multinational for-profit hospital and healthcare that operates 32 hospitals and a network of other healthcare facilities in six countries.

Dr. Somashekhar SP, Chairman – Medical Advisory Board, Aster DM Healthcare – GCC, Global Director – Aster International Institute of Oncology – GCC & India, said, “We welcome the SSi Mantra to the Aster Group of hospitals in Dubai, which is the first installation outside of India and which, we believe, marks the start of a major medical milestone in our country.”

Highlights

  • SS Innovations expects this sale to lead to additional International sales.
  • SSi Mantra is the first surgical system to be made in India and one of the only systems in the world that was designed and built to be distinctly cost-effective with broad-spectrum surgical applications.
  • The system has been granted regulatory approval by the Indian Central Drugs Standard Control Organization (“CDSCO”), India’s equivalent of the FDA. CDSCO approval also carries acceptance by over 50 other countries and another approximate 70 countries accept the approval with minimum administrative requirements.
  • SS Innovations’ SSi Mantra has been clinically validated in India through use hundreds of times in more than 40 different types of surgical procedures.

About SS Innovations International

SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product line includes its proprietary “SSi Mantra” surgical robotic system, and “SSi Mudra”, its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SSII’s business operations are headquartered in India and SSII has plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit SSII’s website at ssinnovations.com or LinkedIn for updates

Disclaimer

This communication was produced by Prism MarketView, an affiliate of PCG Advisory Inc., (together “PCG”). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this is ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the “Securities Act”). “PCG” and its affiliates are compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy…

Read Full Disclaimer

Share This Article

 

About the Author

SS Innovations Achieves First International Sale of Flagship Surgical Robotic System

Editor Prism MarketView